Information Provided By:
Fly News Breaks for December 7, 2015
TRP, RNR, PSA, NSC, MCC, LPI, KR, ISLE, EXR, LLY, BBT, AEP, ASPS, ABT
Dec 7, 2015 | 09:51 EDT
Today's noteworthy upgrades include: Abbott (ABT) upgraded to Buy from Hold at Jefferies...Altisource (ASPS) upgraded to Neutral from Sell at Compass Point...American Electric (AEP) upgraded to Buy from Neutral at UBS...BB&T (BBT) upgraded to Strong Buy from Outperform at Raymond James...Eli Lilly (LLY) upgraded to Buy from Hold at Deutsche Bank...Extra Space Storage (EXR) upgraded to Overweight from Sector Weight at KeyBanc...Isle of Capri (ISLE) upgraded to Buy from Hold at Stifel...Kroger (KR) upgraded to Buy from Neutral at Northcoast...Laredo Petroleum (LPI) upgraded to Hold from Reduce at KLR Group...Medley Capital (MCC) upgraded to Outperform from Market Perform at Wells Fargo...Norfolk Southern (NSC) upgraded to Equal Weight from Underweight at Barclays...Public Storage (PSA) upgraded to Sector Weight from Underweight at KeyBanc...RenaissanceRe (RNR) upgraded to Neutral from Reduce at Nomura...TransCanada (TRP) upgraded to Outperformer from Sector Performer at CIBC.
News For ABT;ASPS;AEP;BBT;LLY;EXR;ISLE;KR;LPI;MCC;NSC;PSA;RNR;TRP From the Last 2 Days
LLY
Mar 28, 2024 | 16:23 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
KR
Mar 28, 2024 | 09:53 EDT
Telsey Advisory analyst Joseph Feldman raised the firm's price target on Kroger to $62 from $60 and keeps an Outperform rating on the shares. The firm's meetings with Kroger and investors have increased the firm's visibility and confidence in Kroger's sustainable long-term growth opportunity, the analyst tells investors. Further, Kroger is transitioning to a food-first model from traditional food retail. This transition should create new growth areas that are significantly more profitable than food retail and should boost the profit profile over time, the firm adds.
PSA
Mar 28, 2024 | 04:47 EDT
Raymond James analyst Jonathan Hughes double upgraded Public Storage to Strong Buy from Market Perform with a $330 price target. The analyst believes the company's recent revenue growth outperformance can be sustained versus peers due to more rent upside after less-aggressive rate increases over the past several years. The firm also expects Public Storage's revenue growth to inflect positively by mid-year, likely sooner than peers.
PSA
Mar 26, 2024 | 16:29 EDT
Barclays initiated coverage of Public Storage with an Overweight rating and $330 price target.
NSC
Mar 26, 2024 | 08:59 EDT
Ohio-based Ancora Holdings Group announced that it is filing a definitive proxy statement with the U.S. Securities and Exchange Commission in connection with its nomination of seven highly qualified director candidates for election to the Company's Board of Directors at the 2024 Annual Meeting of Shareholders scheduled for May 9. Additionally, Ancora sent a letter to shareholders regarding its leadership team's three-year path to superior performance and significant value creation at Norfolk Southern.
LLY
Mar 26, 2024 | 07:08 EDT
JPMorgan estimates Amgen (AMGN) without its obesity pipeline is worth $240-$250 per share and that the market is assigning $30-$40 per share of value to Maritide. While the competitive bar for Maritide is high and moving higher based on Novo Nordisk's (NVO) recent pipeline updates, the obesity market is also "unprecedented in terms of size," the analyst tells investors in a research note. The firm estimates peak sales for Maritide of $6B, equating to mid-single-digit share within the incretin space. JPMorgan believes this supports a value roughly in-line with what is reflected in Amgen's current share price. It sees a positive risk/reward scenario given the recent pullback but maintains a Neutral rating on the name with a $290 price target. The firm says Amgen is viewed as the best positioned name beyond Eli Lilly (LLY) and Novo to have a role in the obesity space.